ALLIUM-PHARMA®
Pharmaceutical-grade Allium sativum.
Four cultivar lines under field stabilisation: Strămoșesc, Violet Spring, Krasnyi Imperator Tibeta, Lyubasha. Allicin profiles and full phytochemical dossiers under NDA.
Programmes
Origin programmes and applied products
Eight programmes operate under the TEHNOFARM® pharmaceutical mandate. Six are B2B origin programmes — pharmaceutical-grade cultivation and supply for industrial partners. One is the B2B platform brand operating one operational layer above the origin work. One is the applied software product — constitutional medical autonomy for distant environments.
B2B Origin Programmes
Six pharmaceutical-grade cultivation programmes. Each is an active R&D framework with documented analytical profiles, regulated supply chain, and field execution by NORD NUC S.R.L. under Moldovan phytosanitary registration.
GINKGO-PHARMA®
Pharmaceutical-grade Ginkgo biloba leaf.
European in-region cultivation for the EGb 761-type extract profile. 0.300 ha active plantation in Corbu, Donduşeni raion.
SAFFRON-PHARMA®
Crocus sativus — Moldovan genetic line.
Apocarotenoid pigments (crocins, picrocrocin, safranal) for neurological and mood-related research.
ZAFFERANO-PHARMA®
Crocus sativus — Italian genetic line.
Parallel Italian-origin counterpart to SAFFRON-PHARMA®. One R&D framework with two origin claims.
JUGLON-PHARMA®
Juglans nigra leaf and bark.
Juglone, tannins, and flavonoid fractions. 1.050 ha Juglans nigra plantation in Corbu.
PONCIRUS-PHARMA®
Frost-hardy Poncirus trifoliata.
Five pharmaceutical research directions across flavonoids, limonoids, and coumarins. Moldovan winter conditions yield stress-validated profile.
B2B Platform
Brand under build
DMT DIVINEMINDTHERAPY® — B2B platform brand for institutional distributors and private-label customers. Trademark filed at AGEPI (Nr. 057329). Operational scope being finalised.
Applied product
T.E.H.N.O.F.A.R.M. OS
Medical mission control for the moments medicine cannot reach.
Constitutional medical software for environments where physicians cannot reach in time — space programmes, polar stations, deep-water vessels, humanitarian field operations, rural primary-care contexts. In active development. Patent foundation filed at AGEPI.